![Amer Zeidan: And the call we had tonight made my week…](https://oncodaily.com/pub/uploads/2023/12/Amer-Zeidan.jpg)
Amer Zeidan: And the call we had tonight made my week…
Amer Zeidan shared on X/Twitter:
“One of my patients established a tradition where he and his wife call me every year on the anniversary of his diagnosis with AML. Tonight was his 9th anniversary (he is in early 80s and was diagnosed early 70s and cured with intensive chemo) and the call we had tonight made my week…”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center.
Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023